Skip to content

Cerebral and Circulatory Effects of Neonatal Volume Targeted Ventilation

Cerebral Oxygenation and Circulatory Parameters During Pressure Controlled vs. Volume Targeted Mechanical Ventilation in the Extremely Preterm Infants With Respiratory Distress Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04391634
Enrollment
25
Registered
2020-05-18
Start date
2017-08-01
Completion date
2018-05-30
Last updated
2020-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth, Respiratory Distress Syndrome, Newborn, Respiratory Failure

Brief summary

The aim of the study was to assess the effect of volume targeted vs. pressure-controlled mechanical ventilation (MV) on circulatory parameters and cerebral oxygenation in the extremely preterm infants.

Detailed description

Prospective, cross-over trial enrolling neonates \<28 weeks' gestation requiring MV. Patients were ventilated for 3 hours with pressure controlled assist-control (PC-AC) mode, followed by 3-hours of volume guarantee assist-control ventilation (VG-AC). Continuous monitoring was carried out using pulse oximetry (oxygen saturation - SpO2 and heart rate - HR), near-infrared spectroscopy (cerebral oxygenation - StO2) and electrical cardiometry (circulatory parameters).

Interventions

OTHERvolume guarantee

volume guarantee assist-control mechanical ventilation

OTHERpressure-controlled

pressure-controlled assist-control mechanical ventilation

Sponsors

Poznan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

prospective crossover study

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 27 Weeks
Healthy volunteers
No

Inclusion criteria

* premature infants born \<28 weeks of gestation * respiratory failure in the course of respiratory distress syndrome requiring mechanical ventilation * stable condition with pH (acidity of blood)\> 7.2 and pCO2 (carbon dioxide partial pressure) \<60 mmHg in the blood gas analysis * no identified genetic syndromes and serious congenital malformations

Exclusion criteria

* lack of written consent of patients' parents

Design outcomes

Primary

MeasureTime frameDescription
StO26 hoursCerebral oxygenation measured using near-infrared spectroscopy \[percent\]
Stroke volume6 hoursStroke volume (SV) monitored with electrical cardiometry \[ml\]
Cardiac output6 hoursCardiac output (CO) monitored with electrical cardiometry \[L/min\]
Stroke index6 hoursStroke index (SI) monitored with electrical cardiometry \[ml/m2\]
Cardiac index6 hoursCardiac index (CI) monitored with electrical cardiometry \[L/min/m2\]
Stroke volume variation (SVV)6 hoursStroke volume variation (SVV) monitored with electrical cardiometry \[percent\]
Index of contractility6 hoursIndex of contractility (ICON) monitored with electrical cardiometry

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026